Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNA-electroporated dendritic cell vaccination for multiple myeloma
NL-OMON27113Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2007
- Countries
- 1
01
Overview
Open-label, single-arm trial in multiple myeloma (MM), sponsored by Radboud University Medical Center. Primary endpoint: Tumor antigen-specific in vivo immune response. Started Oct 2007; status: active, not recruiting.
02
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NL-OMON27113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27113.